However, the literature published before 2021 is based on the 2016 WHO classification (or earlier versions), where the term “GBM” includes not only IDH-wildtype GBM but also the newly classified Grade 4 IDH-mutant astrocytoma [22]. The gene discussed is IDH2; the disease is glioblastoma.